I migliori medici per il trattamento di Linfoma - TOP-93 medici

Come uno dei principali specialisti del linfoma in Turchia, il Professor Gulbas ha fondato il Centro Trapianti di Midollo Osseo presso l'Anadolu Medical Center. Ha eseguito oltre 900 procedure.

• Con oltre 29 anni di esperienza in malattie ematologiche, incluso il linfoma
• Invitato appositamente dal MD Anderson Cancer Center per dirigere il programma di trapianto
• Capo del Dipartimento di Oncoematologia presso l'Anadolu Medical Center
• Membro delle società ematologiche americana ed europea
• Ha seguito una formazione internazionale avanzata in centri negli Stati Uniti, Canada e Israele

Il Dott. Bülent Karagöz è specializzato in linfoma, con un focus sulla biologia tumorale, l'immunoterapia e le terapie mirate. La sua esperienza oncologica di oltre 20 anni garantisce cure avanzate.

• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul
• Autore di oltre 40 pubblicazioni nella ricerca sul cancro
• Membro dell'Associazione Turca di Oncologia Medica
• Capo dell'Oncologia Medica presso l'Ospedale di Formazione GATA Haydarpasa

Esperto di linfomi presso il Sourasky Medical Center con oltre 30 anni di esperienza specializzata in oncologia.

• Professore associato di Oncologia presso l'Università di Tel-Aviv
• Membro del corpo docente ESMO specializzato in sarcomi e linfomi
• Ampio background di ricerca con collaborazioni presso il Weizmann Institute
• Ex capo della Divisione di Oncologia presso il Sourasky
• Membro attivo di ASCO e IASLC per i progressi in oncologia

Il medico è un ostetrico e ginecologo altamente esperto con oltre 25 anni nel campo. Specializzandosi in Medicina della Riproduzione in Ostetricia e Ginecologia, il medico è esperto in trattamenti come Inseminazione Intrauterina (IUI), Procedura di Induzione dell'Ovulazione, Perforazione Ovarica e gestione delle Valvole Uretrali.<\/p>

Il medico ha completato una borsa di studio presso il Ronald O Perelman e Claudia Cohen Centre, possiede un diploma dall'Irlanda e ha conseguito un MBBS presso l'Università di Mysore, India.<\/p>

Il medico è certificato dal consiglio in Medicina Interna, Ematologia e Oncologia Medica. Il percorso professionale include una residenza presso la State University of New York a Brooklyn e una borsa di studio in Ematologia e Oncologia presso il New York Medical College, Westchester Medical Center.<\/p>

Con un forte impegno nel campo medico, il medico ha pubblicato oltre 30 articoli scientifici e ha contribuito a un capitolo di un libro di testo medico. La competenza è ulteriormente dimostrata dall'esecuzione di diverse centinaia di trapianti di cellule staminali, evidenziando l'esperienza in questo settore.<\/p>

Il medico è il capo del Dipartimento di Oncoematologia e Oncologia Pediatrica presso l'Ospedale Pediatrico Dana Dwek. Specializzandosi in trapianti di midollo osseo e sangue del cordone ombelicale per bambini, il medico ha effettuato oltre 300 trapianti. Con una forte presenza accademica, il medico ha pubblicato 50 articoli e presentato 40 relazioni in varie conferenze mediche. Il medico è membro dell'Associazione Americana di Ematologia e della Società Israeliana di Emato-oncologia Pediatrica, e ha praticato presso il City of Hope Hospital di Los Angeles e in vari centri medici in Israele.<\/p>

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Dr. Omur Gokmen Sevindik is a hematologist at Istanbul Florence Nightingale Hospital. He completed a fellowship at the Mayo Clinic, a top-ranked medical center in the US. Dr. Sevindik specializes in treating blood cancers like leukemia and lymphoma. He works at a JCI-accredited facility that treats 300,000 patients annually.

• Performs allogeneic and haploidentical stem cell transplantations.
• Authored 18 articles in international peer-reviewed journals.
• Presented research findings at over 25 international scientific conferences.
• Treats complex conditions including myeloma, aplastic anemia, and thrombocytopenia.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (EBMT)
• Hematologic Oncology Association
• Antalya Medical Chamber

Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.

• Member of the International Society of Pediatric Oncology (SIOP).
• Active member of the European Bone Marrow Transplant Group (EBMT).
• Published more than 40 articles on stem cell therapy and blood disorders.
• Works at a center performing the highest number of transplants in Turkey.

Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.

She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.

She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.

Il medico è un ematologo pediatrico con specializzazione nel trapianto di midollo osseo. Con una vasta esperienza in ematologia pediatrica, il medico ha contribuito in modo significativo ai progressi nel trattamento dei disturbi del sangue nei bambini. Il medico è noto per l'implementazione di tecniche di trapianto innovative che migliorano i risultati dei pazienti e ha pubblicato numerosi articoli di ricerca su riviste mediche di primo piano.<\/p>

Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>

Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>

Dr. Toluy Ozgumus is a hematologist at Hisar Hospital Intercontinental in Istanbul. He has diagnosed and treated over 1,000 patients with bleeding and coagulation disorders. He specializes in the treatment of rare hematological cancers and bone marrow transplantation. Dr. Ozgumus works at a JCI-accredited facility recognized for excellence in hematology-oncology.

• Performs allogenic bone marrow transplants from both related and unrelated donors.
• Treats complex blood cancers including acute leukemia, multiple myeloma, and lymphomas.
• Expert in managing hematological findings related to Covid-19 infections.
• Differentiates myeloproliferative diseases from other causes of blood cell elevation.

La professoressa Yesim Yıldırım è una professoressa di Oncologia Medica specializzata in trattamenti avanzati come l'immunoterapia del cancro e le terapie mirate.

• Ha oltre 12 anni di esperienza specificamente presso l'Anadolu Medical Center
• Autrice di oltre 80 pubblicazioni, inclusi contributi a un importante manuale di cura del cancro
• Ha completato una formazione specialistica presso la Clinica di Immunoncologia del Mount Vernon Cancer Center a Londra
• Titolare di un certificato di attestazione ESMO, una qualificazione europea chiave in oncologia
• Ricopre anche il ruolo di docente, collegando la pratica clinica con l'educazione medica

Il Prof. Kansoy ha fondato la prima unità di trapianto di midollo osseo pediatrico in Turchia e ha dedicato la sua carriera al linfoma pediatrico e ai trattamenti con cellule staminali.

• Oltre 40 anni in oncologia e ematologia pediatrica
• Specializzato in trapianto di cellule staminali per il linfoma
• Ha fondato diverse unità di trapianto di midollo osseo pediatrico in tutta la Turchia
• Ha pubblicato ampiamente sul trapianto di cellule staminali pediatriche
• Membro del consiglio del Gruppo Europeo per il Trapianto di Midollo Osseo

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia